Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Drug Resistance

Free Subscription Articles published in AIDS Retrieve available abstracts of 20 articles: HTML format

Single Articles

July 2024
1. KARABAY O
   Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'.
   AIDS. 2024;38:1273.
   PubMed    
   
   
   March 2024
2. PAPAIOANNU BORJESSON R, Galli L, Lolatto R, Menzaghi B, et al
   Lower aids-related hospitalizations in women living with HIV multidrug resistance.
   AIDS. 2024;38:435-438.
   PubMed    
   
   
   February 2024
3. GONCALVES P, Barreto J, Santos M, Leal S, et al
   HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019-2021.
   AIDS. 2024 Feb 13. doi: 10.1097/QAD.0000000000003866.
   PubMed     Abstract available
   
   
   March 2023
4. SHEN M, Xiao Y, Rong L, Zhuang G, et al
   The impact of attrition on the transmission of HIV and drug resistance: A mathematical modelling study.
   AIDS. 2023 Mar 6. doi: 10.1097/QAD.0000000000003528.
   PubMed     Abstract available
   
   
   February 2023
5. ALIYU GG, Lawton JG, Mitchell AB, Abimiku AG, et al
   Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load.
   AIDS. 2023;37:333-339.
   PubMed     Abstract available
   
   
   November 2022
6. MILNE RS, Beck IA, Levine M, So I, et al
   Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy.
   AIDS. 2022;36:1949-1958.
   PubMed     Abstract available
   
   
   
7. DUARTE FC, Moura LM, Laranjinha J
   High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
   AIDS. 2022;36:1881-1882.
   PubMed    
   
   
   September 2022
8. CONWAY B, Brenner BG
   Can simplified antiretroviral drug combination therapies resist resistance?
   AIDS. 2022;36:1597-1598.
   PubMed    
   
   
   August 2022
9. WOOD BR, Stekler JD
   Baseline HIV genotype drug resistance testing: is it time for more or less?
   AIDS. 2022;36:1449-1451.
   PubMed    
   
   
   July 2022
10. HUIK K, Hill S, George J, Pau A, et al
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS. 2022 Jul 11. pii: 00002030-990000000-00033.
    PubMed     Abstract available
    
    
    February 2022
11. HUGUELEY B, Mcclung RP, Saduvala N, Oster AM, et al
    Baseline HIV drug resistance testing: 12 U.S. jurisdictions, 2014-2019.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96222.
    PubMed     Abstract available
    
    
    
12. HERMANS LE, Hofstra LM, Schuurman R, Ter Heine R, et al
    HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment - week 96 results from the ITREMA trial.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96229.
    PubMed     Abstract available
    
    
    January 2022
13. GENER AR
    Anticipating HIV drug resistance with appropriate sequencing methods.
    AIDS. 2022;36:147-148.
    PubMed    
    
    
    October 2021
14. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
    HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
    PubMed     Abstract available
    
    
    
15. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    PubMed     Abstract available
    
    
    July 2021
16. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    PubMed     Abstract available
    
    
    June 2021
17. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    PubMed     Abstract available
    
    
    February 2021
18. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    PubMed     Abstract available
    
    
    
19. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    PubMed     Abstract available
    
    
    
20. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.